Complement inhibitory and anticoagulant activities of fractionated heparins
- 1 November 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 36 (4) , 281-292
- https://doi.org/10.1016/0049-3848(84)90319-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Covalently bound conjugates of albumin and heparin: Synthesis, fractionation and characterizationThrombosis Research, 1983
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJournal of Clinical Investigation, 1981
- Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytesJournal of Immunological Methods, 1980
- Heparin: An Old Drug with a New ParadigmScience, 1979
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.The Journal of Experimental Medicine, 1979
- Complement Components Detected on Normal Red Blood Cells Taken into EDTA and CPD1Vox Sanguinis, 1979
- Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.The Journal of Experimental Medicine, 1978
- Improvement of antisera against polypeptide hormonesNature, 1975
- The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparationsCarbohydrate Research, 1974
- A MODIFIED METHOD FOR THE COLORIMETRIC DETERMINATION OF HEPARINCanadian Journal of Physiology and Pharmacology, 1967